College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
East Mediterr Health J. 2023 Jul 31;29(7):580-586. doi: 10.26719/emhj.23.034.
Rejection, hesitancy and low uptake of the COVID-19 vaccine are major public health challenges in Saudi Arabia.
To address COVID-19 vaccine hesitancy and rejection at the King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS) using evidence-based strategies.
A questionnaire was administered electronically to participants at KSAU-HS to understand the reasons for vaccine hesitancy or rejection and develop an evidence-informed vaccination plan. Initial results from March 2021 showed that only 60% of respondents had taken at least 1 COVID-19 vaccine dose. Based on the results of the survey, KSAU-HS designed a 6-month vaccination campaign to raise awareness about the vaccine and its importance and increase acceptability rates. Mass media, social media, and direct messaging as reminders were used to address the barriers identified and to help the university community overcome fears and misconceptions about the COVID-19 vaccine.
The evidence-based interventions helped achieve a significantly high vaccination rate in the university community, with 99.7% of individuals vaccinated by October 2021; one of the highest vaccination rates among public universities in Saudi Arabia.
Evidence-based interventions targeted at specific populations can help address prevailing concerns about the COVID-19 vaccine and other similar public health issues.
在沙特阿拉伯,对 COVID-19 疫苗的拒绝、犹豫和低接种率是主要的公共卫生挑战。
在沙特国王阿卜杜勒阿齐兹健康科学大学 (KSAU-HS) 利用基于证据的策略解决 COVID-19 疫苗犹豫和拒绝问题。
在 KSAU-HS 向参与者进行电子问卷调查,以了解疫苗犹豫或拒绝的原因,并制定基于证据的疫苗接种计划。2021 年 3 月的初步结果显示,只有 60%的受访者至少接种了 1 剂 COVID-19 疫苗。根据调查结果,KSAU-HS 设计了一项为期 6 个月的疫苗接种运动,旨在提高对疫苗及其重要性的认识,并提高可接受率。大众媒体、社交媒体和直接提醒信息被用来解决确定的障碍,并帮助大学社区克服对 COVID-19 疫苗的恐惧和误解。
基于证据的干预措施有助于在大学社区实现非常高的疫苗接种率,到 2021 年 10 月,有 99.7%的人接种了疫苗;这是沙特阿拉伯公立大学中接种率最高的之一。
针对特定人群的基于证据的干预措施可以帮助解决对 COVID-19 疫苗和其他类似公共卫生问题的普遍关注。